Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 70710-1365

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 70710-1365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 01

Chemical structure of emtricitabine, part of the active ingredients in Emtricitabine and tenofovir disoproxil fumarate tablets by Zydus Pharmaceuticals USA Inc. It shows a detailed molecular diagram with atoms and bonds representing the composition of emtricitabine.*

FDA Label Image

D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 02

Chemical structure diagram showing the molecular structure of Emtricitabine and tenofovir disoproxil fumarate, the active ingredients in the product. The diagram depicts detailed atomic connections and functional groups typical of these compounds.*

FDA Label Image

D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 03

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 100 mg/150 mg strength, film-coated oral tablets. The label indicates a package of 30 tablets, prescription only, distributed by Zydus Pharmaceuticals USA Inc. It includes storage instructions, child-resistant packaging information, and manufacturer details (Cadila Healthcare Ltd., Ahmedabad, India). The label features a barcode, NDC 70710-1364-3, and a note for pharmacists to dispense the Medication Guide separately.*

FDA Label Image

D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 04

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 133 mg/200 mg film-coated oral tablets. The label shows the NDC 70710-1365-3, packaging of 30 tablets for prescription use only. It includes storage information, dosage directions, manufacturer Cadila Healthcare Ltd., and distributor Zydus Pharmaceuticals USA Inc. The label also warns that the package is child-resistant and to keep out of reach of children.*

FDA Label Image

D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 05

Packaging label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 167 mg/250 mg film-coated oral tablets. The package contains 30 tablets and is labeled Rx only. Manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. The label includes storage instructions, dosage details, and a warning that the package is child-resistant.*

FDA Label Image

D87907c8 88f3 4bdf Bdc4 3f8e4968f33c 06

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 200 mg/300 mg by Zydus Pharmaceuticals USA Inc. The label includes NDC 70710-1367-3, package size of 30 film-coated tablets for oral use, and manufacturer information (Cadila Healthcare Ltd., India). It has storage instructions and a notice to dispense the Medication Guide to patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.